Analyst Ratings For NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
Today, NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO) stock was downgraded by BMO Capital Markets from Outperform ➝ Market Perform to .
Some recent analyst ratings include
- 5/10/2018-BMO Capital Markets was Downgraded by analysts at BMO Capital Markets from a “Outperform ➝ Market Perform” rating to a “” rating.
- 5/10/2018-Leerink Swann was Downgraded by analysts at Leerink Swann from a “Outperform ➝ Market Perform” rating to a “” rating. They now have a $50.00 price target on the stock.
- 2/20/2018-Robert W. Baird initiated coverage with a Outperform rating.
- 2/20/2018-Jefferies Group initiated coverage with a Buy ➝ Buy rating.
Recent Trading Activity for NASDAQ:ARMO – ARMO BioSciences (NASDAQ:ARMO)
Shares of NASDAQ:ARMO – ARMO BioSciences closed the previous trading session at 49.80 up +19.98 67.00% with 49.7599983215332 shares trading hands.